<p>WT (n = 6) (●), T1DM (n = 6) (○) and T1DM/AFB1 (n = 4) (▼) following buffer alone or STZ treatment.</p
(A) Mice were challenged with glucose (2 g/kg, i.p.), and fasting blood glucose was measured at 0, 1...
<p>Values are expressed as mean ± SEM of 5 mice for each group. No significant differences were seen...
<p>Glucose (A) and body weight (B) measurements are plotted for each mouse model (WT Chow, WT HFD, a...
<p>(A) MT-tg (n = 8) and WT (n = 7) male mice; (B) MT-tg (n = 13) and WT (n = 21) female mice. * p<0...
<p>Blood glucose levels measured at the indicated times after transplanting pancreatic IPCs into dia...
<p>The graph shows blood glucose levels in control or STZ-treated OX<sup>−/−</sup> and C57BL/6 mice ...
<p>Panels A and B are average measurements of, respectively, non-fasting blood glucose and BLI signa...
To establish the parsimonious model for blood glucose monitoring in patients with type 2 diabetes re...
<p>*p<0.001 for the main effect of glucose infusion using a two-way repeated measures ANOVA. There w...
(A) Plasma concentration of AAT was measured in control and STZ mice. (B) Schematic showing the time...
<p>Glucose tolerance was measured by quantifying plasma glucose after an intraperitoneal injection o...
<p>Mice received the indicated sample treatments for 5 weeks. Diabetes was induced by multiple (for ...
<p>The blood glucose (A) was measured by glucose detection kit, and the mRNA levels for AGT (B), ACE...
<p>Blood glucose levels were measured before (0 min) and after glucose injection, several times up t...
<p>A. Non-fasted (random) blood glucose throughout the treatment and monitoring phases. B. IPGTT com...
(A) Mice were challenged with glucose (2 g/kg, i.p.), and fasting blood glucose was measured at 0, 1...
<p>Values are expressed as mean ± SEM of 5 mice for each group. No significant differences were seen...
<p>Glucose (A) and body weight (B) measurements are plotted for each mouse model (WT Chow, WT HFD, a...
<p>(A) MT-tg (n = 8) and WT (n = 7) male mice; (B) MT-tg (n = 13) and WT (n = 21) female mice. * p<0...
<p>Blood glucose levels measured at the indicated times after transplanting pancreatic IPCs into dia...
<p>The graph shows blood glucose levels in control or STZ-treated OX<sup>−/−</sup> and C57BL/6 mice ...
<p>Panels A and B are average measurements of, respectively, non-fasting blood glucose and BLI signa...
To establish the parsimonious model for blood glucose monitoring in patients with type 2 diabetes re...
<p>*p<0.001 for the main effect of glucose infusion using a two-way repeated measures ANOVA. There w...
(A) Plasma concentration of AAT was measured in control and STZ mice. (B) Schematic showing the time...
<p>Glucose tolerance was measured by quantifying plasma glucose after an intraperitoneal injection o...
<p>Mice received the indicated sample treatments for 5 weeks. Diabetes was induced by multiple (for ...
<p>The blood glucose (A) was measured by glucose detection kit, and the mRNA levels for AGT (B), ACE...
<p>Blood glucose levels were measured before (0 min) and after glucose injection, several times up t...
<p>A. Non-fasted (random) blood glucose throughout the treatment and monitoring phases. B. IPGTT com...
(A) Mice were challenged with glucose (2 g/kg, i.p.), and fasting blood glucose was measured at 0, 1...
<p>Values are expressed as mean ± SEM of 5 mice for each group. No significant differences were seen...
<p>Glucose (A) and body weight (B) measurements are plotted for each mouse model (WT Chow, WT HFD, a...
DOI
Add to ORKG